BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, July 10, 2026
Home » Authors » Katie Pfaff

Articles by Katie Pfaff

Diabetes management software maker awarded class III FDA approval

June 26, 2017
By Katie Pfaff

Scanner detects developing bedsores to treat proactively

June 23, 2017
By Katie Pfaff

Clearflow plans to improve chest drain care with Flowglide clearance device

June 22, 2017
By Katie Pfaff

OSU tests vest for heart failure management

June 21, 2017
By Katie Pfaff

Stryker to buy Novadaq for $701 million

June 20, 2017
By Katie Pfaff

Mindstrong Health earns $14M in series A financing

June 19, 2017
By Katie Pfaff

Neurotech start up seeks to disrupt sleep device market

June 16, 2017
By Katie Pfaff

Infuseon Therapeutics wins FDA clearance for CNS delivery device

June 15, 2017
By Katie Pfaff

Myomo offers robotics industry IPO

June 14, 2017
By Katie Pfaff
Medical robotics company Myomo Inc. goes public with IPO offering of $5 million at $7.50 per share. The Cambridge, Mass., company specializes in mobility devices for the arms and hands. The company's initial public offering was for 665,498 shares of common stock, sold at $7.50 per share for a total of $5 million. An additional private investment sale of restricted securities resulted in $2.9 million, totaling $7.9 million for Myomo. The private sale was closed primarily to those already investing in the company. Cash flow is expected to be used in the company's assistive prosthetic...
Read More

Labconnect nets $24.5M in series A to continue growth

June 14, 2017
By Katie Pfaff
Previous 1 2 … 16 17 18 19 20 21 22 23 24 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 9, 2026.
  • 3D rendering of an antibody drug conjugate

    ‘Target-high but uptake-defective’ state identified in ADC resistance

    BioWorld
    Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
  • Illustration of brain and brain waves, concept of focal seizure

    Hyperexcitability may be joint problem in epilepsy, dementia

    BioWorld
    The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
  • Modius Spero wearable neuromodulation device

    Neurovalens granted FDA approval for PTSD therapy for US veterans

    BioWorld
    Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
  • Art concept for medical research

    FENS 2026: Shedding light on the sheddome

    BioWorld
    At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing